Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Imdevimab Emergency use authorization Experimental Antiviral Jan/23/2023 31 11
Casirivimab Emergency use authorization Experimental Antiviral Jan/23/2023 26 16
T cells Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023 24 0
Nirmatrelvir Emergency use authorization Experimental Antiviral Jun/23/2022 7 0
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 11 15
Etesevimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 5 16
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 64 0
S309 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/22/2022 11 0
Ad26.COV2.S Emergency use authorization Experimental Vaccine Jun/22/2022 10 1
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 26 1